Low-Dose Tadalafil and Cabergoline versus Cabergoline alone in Management of Erectile Dysfunction in Patients with End-Stage Renal Disease and Hyperprolactinemia Undergoing Hemodialysis
Background: Hyperprolactinemia in chronic kidney disease (CKD) is associated with high rates of hypogonadism and erectile dysfunction (ED). This study compares the efficacy, safety, and side effects of cabergoline monotherapy versus low-dose tadalafil combined with cabergoline in treating ED in end-...
محفوظ في:
| المؤلفون الرئيسيون: | , , , |
|---|---|
| التنسيق: | Artigo |
| اللغة: | Inglês |
| منشور في: |
Al-Azhar University, Faculty of Medicine
2025-04-01
|
| سلاسل: | Al-Azhar International Medical Journal |
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://aimj.journals.ekb.eg/article_451286_aec564eda8f818c26b85dbbcb7453ac4.pdf |
| الوسوم: |
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|